AZOAutoZone
- Next report
- Dec 8
- Tuesday, in 26 days · time not announced yet
- EPS expected
- $36.06
- quarter ending Nov 30, 2026
- Last result
- $38.07Beat
- vs $36.09 expected on May 26
- Stock move on it
- −8.99%
- one session
- Price
- $3,259.35
- +0.67% today · $51.9B cap
Past and upcoming reports
2
| Dec 8, 2026 | Nov 30, 2026 | Time not announced yet | $36.06 | not yet | |
| May 26, 2026 | May 31, 2026 | Before the market opens | $36.09 | Beat$38.07 | −8.99% |
Pre-earnings read
No pre-earnings read for this report
None for this company right now.
After the report
May 26, 2026 report
AutoZone beats EPS estimates by 5.1% but shares decline amid margin concerns
AutoZone reported Q1 EPS of $38.07 versus $36.22 estimated, a 5.1% beat, yet shares fell 0.9% post-earnings. Despite the EPS beat, the stock remains below key moving averages with weak recent price performance and mixed growth signals. Investors await upcoming quarterly sales updates to assess domestic growth stability and margin trends.
Reported against expected
AutoZone reported EPS of $38.07, beating the estimate of $36.22 by 5.1%.
Guidance
No explicit guidance was provided in the payload. growth signals are mixed with 16% EPS growth expected next year but below-sector revenue growth.
How the stock reacted
Shares declined 0.9% on the day of the report, trading below 50- and 200-day SMAs, reflecting investor caution despite the EPS beat.
What changed
Q1 EPS beat estimates by 5.1% with reported EPS at $38.07 versus $36.22 expected.
What the price now assumes
The 0.9% share price decline post-earnings signals investor concern over margin pressures despite the EPS beat.
What it means for the business
Maintain a neutral stance. monitor upcoming sales updates for margin and growth trajectory clarity.
The next one to three months, as we saw it then
Better case30%
Sales growth stabilizes or improves, supporting margin expansion and EPS growth above current estimates.
Base case50%
Sales growth remains subdued with modest margin pressure, resulting in steady but unspectacular earnings growth.
Worse case20%
Sales growth declines further, pressuring margins and earnings, leading to share price weakness.
If you hold it
Hold unless quarterly sales growth declines further or operating margin falls below 17%.
If you are watching
Consider entry if sales growth stabilizes or improves with margin expansion. avoid if sales decline accelerates or margins deteriorate.
Scenario odds are a judgement, not measured.